M&A Deal Summary

Schwarz Pharma Acquires Aderis Pharmaceuticals

On July 15, 2005, Schwarz Pharma acquired healthcare services company Aderis Pharmaceuticals for 80M USD

Acquisition Highlights
  • This is Schwarz Pharma’s 1st transaction in the Healthcare Services sector.
  • This is Schwarz Pharma’s largest (disclosed) transaction.
  • This is Schwarz Pharma’s 1st transaction in the United States.
  • This is Schwarz Pharma’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2005-07-15
Target Aderis Pharmaceuticals
Sector Healthcare Services
Buyer(s) Schwarz Pharma
Deal Type Add-on Acquisition
Deal Value 80M USD
Advisor(s) Needham & Co. LLC (Financial)

Target

Aderis Pharmaceuticals

Hopkinton, Massachusetts, United States
Aderis Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development, manufacture, and commercialization of pharmaceuticals for the therapeutic treatment of central nervous system, cardiovascular, and inflammatory diseases.

Search 198,123 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Schwarz Pharma

Shannon, Ireland
Category Company
Founded 1979
Sector Healthcare Services
DESCRIPTION

Schwarz Pharma Ltd. manufactures pharmaceutical products.

DEAL STATS #
Overall 1 of 1
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Massachusetts) 1 of 1
Country (United States) 1 of 1
Year (2005) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal